Ligand Pharmaceuticals Balance Sheet (2010-2026) | LGND

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	21.86M	23.43M	19.52M	14.99M	5.28M	4.12M	45.01M	88.73M	28.45M	19.27M	22.95M	50.09M	18.14M	63.62M	72.31M	47.99M	67.67M	139.38M	174.93M	115.08M
Short-term Investments (Quarter)	279.97M	299.78M	321.59M	189.01M	142.66M	117.29M	166.86M	193.94M	190.60M	171.23M	147.35M	260.50M	208.79M	11.13M	183.86M	160.91M	177.35M	525.15M	15.63M	664.33M
Cash & Current Investments (Quarter)	301.83M	323.21M	341.11M	204.00M	147.94M	121.41M	211.87M	282.67M	219.04M	190.50M	170.31M	310.59M	226.93M	74.75M	256.17M	208.90M	245.02M	664.52M	190.56M	779.40M
Receivables - Net (Quarter)	58.16M	64.34M	85.45M	41.80M	62.31M	65.17M	30.42M	29.19M	27.99M	36.00M	32.92M	28.43M	37.48M	34.32M	38.38M	38.49M	41.29M	57.56M	59.60M	53.38M
Receivables - Other (Quarter)
Receivables (Quarter)	58.16M	64.34M	85.45M	41.80M	62.31M	65.17M	30.42M	29.19M	27.99M	36.00M	32.92M	28.43M	37.48M	34.32M	38.38M	38.49M	41.29M	57.56M	59.60M	53.38M
Raw Materials (Quarter)											0.42M		1.49M	2.50M	0.60M
Work In Process (Quarter)											0.20M		0.55M	0.26M	3.92M
Inventory (Quarter)	39.95M	33.00M	27.33M	25.61M	24.77M	22.33M	13.29M	14.01M	26.91M	25.39M	23.97M	21.34M	18.67M	16.74M	14.11M	14.61M	15.49M	11.90M	9.13M	13.27M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	6.27M	5.16M	3.57M	4.66M	7.80M	10.75M	2.27M	2.33M	2.77M	2.10M	2.66M	7.31M	7.12M	19.74M	8.81M	13.29M	4.82M	6.99M	5.79M	5.79M
Current Assets (Quarter)	410.90M	432.08M	464.75M	276.07M	243.78M	220.43M	263.60M	328.19M	276.71M	253.99M	237.43M	368.91M	312.26M	309.39M	331.56M	309.32M	352.94M	753.92M	832.27M	865.41M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	17.63M	18.70M	13.19M	24.58M	30.95M	33.42M	12.48M	11.74M	11.38M	16.18M	15.61M	15.13M	14.97M	15.09M	15.13M	3.62M	3.63M	3.47M
Long-Term Investments (Quarter)	375.00M	375.00M	375.00M	375.00M	375.00M	375.00M	3.00M	375.00M	375.00M	33.10M	12.60M	36.50M	34.51M	10.91M		10.91M	12.70M	42.00M	121.45M	13.53M
Goodwill (Quarter)	190.52M	190.18M		105.70M	181.21M			105.67M	105.67M	3.71M	3.71M	105.25M	105.25M	105.25M	105.25M	101.54M	101.54M	101.54M	101.54M	101.54M
Intangibles (Quarter)	572.01M	562.37M	376.69M	539.71M	528.36M	517.02M	342.45M	333.92M	325.38M	314.84M	299.61M	291.42M	283.16M	274.90M	266.65M	258.39M	250.13M	233.53M	225.44M	217.34M
Goodwill & Intangibles (Quarter)	762.52M	752.55M	376.69M	645.41M	709.57M	517.02M	342.45M	439.59M	431.05M	318.55M	303.31M	396.67M	388.41M	380.15M	371.90M	359.93M	351.67M	335.08M	326.98M	318.88M
Long-Term Deferred Tax (Quarter)	27.88M	26.73M	35.73M	35.66M	35.65M	35.50M	8.53M	0.88M	8.53M	8.53M	0.21M		0.19M	0.08M	0.07M	0.55M	0.83M	9.53M	8.35M	8.47M
Other Non-Current Assets (Quarter)	2.83M	3.10M	270.78M	6.44M	6.32M	6.28M	1.74M	4.63M	4.50M	8.43M	6.39M	11.22M	11.92M	8.40M	31.73M	7.89M	9.11M	2.77M	12.58M	12.99M
Non-Current Assets (Quarter)	845.38M	841.57M	832.84M	829.12M	832.50M	830.17M	499.07M	482.88M	481.39M	515.23M	549.79M	544.96M	554.15M	645.48M	610.22M	596.12M	595.66M	722.85M	728.37M	666.69M
Assets (Quarter)	1,256.28M	1,273.66M	1,297.59M	1,105.18M	1,076.29M	1,050.61M	762.67M	811.08M	758.11M	769.23M	787.22M	913.87M	866.40M	954.87M	941.77M	905.43M	948.60M	1,476.77M	1,560.64M	1,532.11M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	17.27M	7.23M	8.40M	6.97M	19.15M	15.89M	5.31M	6.13M	9.58M	2.48M	2.43M	1.89M	1.79M	4.69M	5.23M	5.37M	8.58M	3.68M	3.24M	5.26M
Notes Payables (Quarter)
Payables (Quarter)	17.27M	7.23M	8.40M	6.97M	19.15M	15.89M	5.31M	6.13M	9.58M	2.48M	2.43M	1.89M	1.79M	4.69M	5.23M	5.37M	8.58M	3.68M	3.24M	5.26M
Accumulated Expenses (Quarter)	10.11M	12.24M	17.58M	15.88M	14.55M	19.34M	15.68M	14.98M	7.29M	10.63M	12.47M	12.43M	12.17M	15.60M	27.91M	23.54M	17.46M	24.08M	31.45M	31.84M
Other Accumulated Expenses (Quarter)							0.46M		0.45M	0.92M					1.30M			0.14M	0.14M	0.30M
Short term Debt (Quarter)					114.97M	76.60M	76.69M	76.79M
Current Leases (Quarter)	2.27M	2.23M	1.41M	0.05M	0.05M	2.39M	0.04M	0.04M	0.68M	0.50M	0.01M	1.00M	0.01M	1.07M	1.27M	0.02M	0.02M	1.09M	1.09M	1.09M
Current Taxes (Quarter)				5.80M	3.78M	9.70M			11.39M	1.20M		1.14M	2.09M	2.11M	1.20M	1.80M	0.30M	1.28M	1.24M	1.89M
Current Deferred Revenue (Quarter)	17.15M	12.01M	0.65M	10.50M	10.58M	9.55M	0.35M	0.26M			1.22M	1.23M	1.20M	1.15M	1.28M	0.10M	0.11M
Curent Deferred Tax Liability (Quarter)
Total Current Liabilities (Quarter)	52.50M	36.30M	41.66M	42.58M	167.85M	135.24M	98.81M	98.93M	29.39M	15.73M	16.78M	17.82M	18.57M	24.77M	37.11M	58.68M	64.73M	30.54M	37.45M	40.67M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)																		445.49M	446.19M	446.90M
Convertible Debt (Quarter)	315.32M	316.89M	320.72M	176.54M
Non-Current Deffered Revenue (Quarter)			9.27M		7.43M	5.54M	0.04M				1.44M	3.06M	2.70M	2.51M	2.25M
Preferred Stock Liabilities (Quarter)
Minority Interest (Quarter)
Liabilities from Discontinued Operations (Quarter)			55.53M													25.51M	35.69M
Non-Current Deferred Tax Liability (Quarter)	60.05M	63.03M	72.31M	39.48M	42.67M	29.83M	30.61M	30.01M	27.66M	32.59M	31.62M	50.61M	30.13M	46.40M	73.14M	29.38M	32.25M	22.67M	36.02M	22.61M
Operating Leases (Quarter)	4.77M	13.77M	2.26M	18.70M	27.09M	34.89M	10.34M	11.18M	10.99M	5.83M	6.18M	5.19M	6.42M	6.27M	7.15M	0.80M	4.63M	4.42M	4.20M	3.99M
Other Non-Current Liabilities (Quarter)	28.01M	27.13M	29.55M	29.19M	21.92M	21.95M	27.76M	21.86M	21.66M	43.67M	27.76M	27.78M	29.35M	29.87M	30.16M	14.25M	14.37M	19.91M	16.63M	17.11M
Total Non-Current Liabilities (Quarter)	441.76M	434.46M	446.88M	282.80M	252.00M	212.36M	137.43M	142.90M	71.55M	57.66M	58.55M	79.57M	61.86M	83.81M	81.17M	95.65M	105.71M	506.69M	526.80M	517.67M
Total Liabilities (Quarter)	469.77M	461.59M	476.43M	311.99M	273.92M	234.31M	165.18M	164.76M	93.21M	101.33M	86.30M	107.35M	91.21M	113.69M	111.33M	109.90M	120.08M	526.60M	543.42M	534.78M
Shareholder's Equity
Total Debt (Quarter)					114.97M	76.60M	76.69M	76.79M										445.49M	446.19M	446.90M
Common Equity (Quarter)	786.52M	812.07M	821.16M	793.19M	802.37M	816.30M	597.49M	646.32M	664.89M	667.90M	700.91M	806.52M	775.20M	841.18M	830.44M	795.59M	827.31M	950.17M	1,017.21M	997.32M
Shareholder's Equity (Quarter)	786.52M	812.07M	821.16M	793.19M	802.37M	816.30M	597.49M	646.32M	664.89M	667.90M	700.91M	806.52M	775.20M	841.18M	830.44M	795.59M	827.31M	950.17M	1,017.21M	997.32M
Liabilities and Shareholders Equity (Quarter)	1,256.28M	1,273.66M	1,297.59M	1,105.18M	1,076.29M	1,050.61M	762.67M	811.08M	758.11M	769.23M	787.22M	913.87M	866.40M	954.87M	941.77M	905.43M	948.60M	1,476.77M	1,560.64M	1,532.11M
Treasury Shares (Quarter)	0.26M	0.27M	0.26M	0.16M	0.32M	0.39M	0.35M	0.38M	0.37M	0.37M	0.35M	0.50M	0.51M	0.50M	0.44M	0.47M	0.46M	0.46M	0.46M	0.44M
Retained Earnings (Quarter)	-0.86M	-0.88M	-0.92M	468.84M	467.94M	-1.06M	450.86M	-0.94M	495.10M	-0.94M	503.02M	-0.91M	537.24M	1.75M	-5.94M	-1.56M	8.49M	578.22M	608.09M	5.39M

Research Tools

Developers

Ligand Pharmaceuticals Balance Sheet (2010-2026) | LGND

Research Tools

Developers

Ligand Pharmaceuticals Balance Sheet (2010-2026) | LGND

Create an account

Sign In

Reset Password